Aggarwal, A., V. Gaur and A. Kumar, 2010. Nitric oxide mechanism in the protective effect of naringin against Post-Stroke Depression (PSD) in mice. Life Sci., 86: 928-935.
PubMed  |  

Bali, A., K. Sharma, A. Bhalla, S. Bala, D. Reddy, A. Singh and A. Kumar, 2010. Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics. Eur. J. Med. Chem., 45: 2656-2662.
CrossRef  |  

Bali, A., M. Sarika, H. Dhir, A. Kumar and A. Sharma, 2009. Synthesis and evaluation of 1-(quinoliloxypropyl)-4 aryl piperazines for atypical antipsychotic effect. Bioorg. Med. Chem. Lett., 19: 3041-3044.
PubMed  |  

Gaur, V. and A. Kumar, 2010. Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transisent global ischemia induced behavioral despair: Possible involvement of nitric oxide cyclic guanosine monophosphate study pathway. Brain Res. Bull., 82: 57-64.
PubMed  |  

Gaur, V. and A. Kumar, 2010. Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. Inflammopharmacology, .
PubMed  |  

Gaur, V. and A. Kumar, 2010. Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: Possible involvement of NO-cGMP pathway. Brain Res., 1353: 204-212.
CrossRef  |  

Gaur, V., A. Aggarwal and A. Kumar, 2009. Protective effect of naringin against ischemic reperfusion cerebral injury: Possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur. J. Pharmacol., 616: 147-154.
PubMed  |  

Gupta, A., A. Dhir, A. Kumar and S.K. Kulkarni, 2009. Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats. Pharmacol. Behav. Biochem., 94: 219-226.
PubMed  |  

Gupta, A., A. Dhir, A. Kumar and S.K. Kulkarni, 2010. Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: Behavioral, biochemical and histological evidences. Indian J. Exp. Biol., 48: 577-585.
PubMed  |  

Gupta, A., A. Kumar and S.K. Kulkarni, 2010. Licofelone attenuates MPTP-induced neuronal toxicity: Behavioral, biochemical and cellular evidences. Inflammopharmacology, 18: 223-232.
PubMed  |  

Kalonia, H., P. Kumar and A. Kumar, 2010. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Res., .
PubMed  |  Direct Link  |  

Kalonia, H., P. Kumar and A. Kumar, 2010. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. Behav. Brain Res., .
PubMed  |  

Kalonia, H., P. Kumar and A. Kumar, 2010. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington disease. Pharmacol. Biochem. Behav., 96: 115-124.
PubMed  |  

Kalonia, H., P. Kumar and A. Kumar, 2010. Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats. Eur. J. Pharmacol., 634: 46-52.
CrossRef  |  

Kalonia, H., P. Kumar and A. Kumar, 2011. Licofelone attenuates quinolinic acid induced Huntington like symptoms: Possible behavioral, biochemical and cellular alterations. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, .

Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2009. Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacology, 17: 211-219.
PubMed  |  

Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2010. Protective effect of montelukast against quinolinic acid / malonic acid induced neurotoxicity: Possible behavioral, biochemical, mitochondrial and TNF-Alpha level alterations in rats. Neuroscience, .
PubMed  |  

Kalonia, H., P. Kumar, A. Kumar and B. Nehru, 2010. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats. NeuroToxicology, 31: 195-203.
CrossRef  |  

Kumar, A. and A. Singh, 2009. Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation–induced behaviour modification and oxidative damage in mice. Fundam. Clin. Pharmacol., 23: 439-448.
PubMed  |  

Kumar, A. and Beenta, 2009. Prescription writing trends of antihistaminies at the university health centre. Indian J. Pharm. Sci., 71: 307-309.
CrossRef  |  

Kumar, A. and R. Garg, 2009. Possible role of trazodone and imipramine in sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Method Find. Clin. Pharmacol., 31: 383-387.
PubMed  |  

Kumar, A., A. Prakash and S. Dogra, 2010. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by d-galactose in mice. Food Chem. Toxicol., 48: 626-632.
CrossRef  |  

Kumar, A., A. Vashist and P. Kumar, 2010. Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioral, biochemical and mitochondrial alterations in mice. Inflammopharmacology, 18: 241-251.
PubMed  |  

Kumar, A., B. Kumari and P. Kumar, 2010. Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress. Neurosci. Bull., 26: 17-27.
PubMed  |  

Kumar, A., R. Garg and A.K. Prakash, 2010. Effect of St. John`s Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice. BMC Complemen. Altern. Med., 10: 18-18.
PubMed  |  

Kumar, A., R. Garg, V. Gaur and P. Kumar, 2009. Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress induced behavioral and biochemical alteration in rats. Neurosci. Lett., 467: 72-75.
CrossRef  |  

Kumar, A., R. Garg, V. Gaur and P. Kumar, 2010. Possible role of NO modulators in protective effect of trazodone and citalopram (antidepressants) in acute immobilization stress in mice. Indian J. Exp. Biol., 48: 1131-1135.
PubMed  |  

Kumar, A., R. Garg, V. Gaur and P. Kumar, 2010. Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. Brain Res., 1311: 73-80.
CrossRef  |  

Kumar, A., S. Dogra and A. Prakash, 2009. Effect of carvedilol on behavioral, mitochondrial dysfunction and oxidative damage against D-galactose induced senescence in mice. Naunyn-Schmiedeberg`s Arch. Pharmacol., 380: 431-441.
Direct Link  |  

Kumar, A., S. Dogra and A. Prakash, 2009. Neuroprotective effects of Centella asiatica against Intracerebroventricular colchicine-induced cognitive impairment and oxidative stress. Int. J. Alzheimers Dis., 2009: 1-8.
CrossRef  |  

Kumar, A., S. Dogra and A. Prakash, 2009. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav. Brain Res., 205: 384-390.
CrossRef  |  

Kumar, A., S. Dogra and A. Prakash, 2010. Protective effect of naringin, a citrus flavonoid, against colchicine induced cognitive dysfunction and oxidative damage in rats. J. Med. Food, 13: 976-984.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism. Food Chem. Toxicol., 47: 2522-2530.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: Possible role of nitric oxide. Neurosci. Res, 63: 302-314.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical and mitochondrial dysfunction in an animal model of Huntington`s disease. J. Med. Food, 12: 591-600.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington`s disease like symptoms: Possible behavioural, biochemical and cellular alterations. Eur. J. Pharmacol., 615: 91-101.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: Possible nitric oxide mechanisms. Psychopharmacology, 207: 257-270.
PubMed  |  

Kumar, P. and A. Kumar, 2009. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain. Indian J. Exp. Biol., 47: 715-722.
PubMed  |  

Kumar, P. and A. Kumar, 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington`s like symptoms in rats: Possible role of nitric oxide. Behav. Brain Res., 206: 38-46.
PubMed  |  

Kumar, P. and A. Kumar, 2010. Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats. Basic Clin. Pharmacol. Toxicol., 107: 577-582.
PubMed  |  

Kumar, P., H. Kalonia and A. Kumar, 2009. Lycopene modulate nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci., 85: 711-718.
PubMed  |  

Kumar, P., H. Kalonia and A. Kumar, 2009. Sesamol attenuate 3-nitropropionic acid-induced huntington like behavioral, biochemical and cellular alterations in rats. J. Asian Nat. Prod. Res., 11: 439-450.
PubMed  |  

Kumar, P., H. Kalonia and A. Kumar, 2010. Cyclosporine attenuates 3-nitropropionic acid induced huntington`s like symptoms in rat: Possible nitric oxide mechanism. Int. J. Toxicol., 29: 318-325.
CrossRef  |  

Kumar, P., H. Kalonia and A. Kumar, 2010. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington`s disease. Behav. Pharmacol., 21: 217-230.
PubMed  |  

Kumar, P., H. Kalonia and A. Kumar, 2010. Novel protective mechanism of antidepressants against 3-nitropropionic acid induced Huntington’s like symptoms in rats: A comparative study. J. Psychopharmacol. .
Direct Link  |  

Kumar, P., H. Kalonia and A. Kumar, 2010. Possible nitric oxide modulation in protective effect of FK506 against 3nitropropioinic acid-induced behavioral, oxidative damage, neurochemical and mitochondrial alterations in rat brain. Drug Chem. Toxicol., 33: 377-392.

Kumar, P., H. Kalonia, A. Kumar and A. Goyal, 2010. 3-nitropropionic acid-induced neurotoxicity as an experimental model of Huntington`s disease: Possible behavioral, biochemical and cellular alterations. J. Pharm. Educ. Res., 2: 26-36.
Direct Link  |  

Prakash, A. and A. Kumar, 2009. Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin. Pharmacol. Toxicol., 105: 98-104.
PubMed  |  

Prakash, A.K. and A. Kumar, 2009. Effect of chronic treatment of carvedilol on oxidative stress in intracerebroventricle streptozotocin-induced model of dementia in rat. J. Pharm. Pharmacol., 61: 1665-1672.
PubMed  |